PODD News and Press, Insulet Corporation From 05/13/24

2024-05-13 06:00:06 ET Matt Miksic from Barclays issued a price target of $200.00 for PODD on 2024-05-13 05:06:00. The adjusted price target was set to $200.00. At the time of the announcement, PODD was trading at $165.9. The overall price target consensus is at $293.15 ...

2024-05-09 20:34:02 ET Insulet Corporation (PODD) Q1 2024 Earnings Conference Call May 09, 2024, 16:30 PM ET Company Participants Deborah Gordon - Vice President, Investor Relations Jim Hollingshead - President and Chief Executive Officer Ana Maria Chadwick - Exe...

2024-05-09 16:24:28 ET More on Insulet Insulet: Insulating Patients, Investors Still Have To Wait Insulet Corporation (PODD) Q4 2023 Earnings Call Transcript Insulet Q1 2024 Earnings Preview Wolfe raises Insulet to outperform, cites increasing market share ...

Raising Full Year Revenue and Operating Margin Guidance Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced financial results for the three months ended Ma...

2024-05-08 17:35:55 ET Major earnings expected after the bell on Thursday include: Unity Software ( U ) Main Street Capital Corporation ( MAIN ) Marathon Digital Holdings ( MARA ) Wheaton Precious Metals Corp. ( WPM ) Blink Charging Co. ( BLNK ) ...

2024-05-08 17:20:22 ET More on Insulet Insulet: Insulating Patients, Investors Still Have To Wait Insulet Corporation (PODD) Q4 2023 Earnings Call Transcript Wolfe raises Insulet to outperform, cites increasing market share DexCom, Insulet, Tandem seen benefi...

2024-05-07 11:56:38 ET More on Insulet Insulet: Insulating Patients, Investors Still Have To Wait Insulet Corporation (PODD) Q4 2023 Earnings Call Transcript DexCom, Insulet, Tandem seen benefitting the most in diabetes survey - Wells Fargo Insulet Omnipod 5 ...

2024-05-07 06:00:04 ET Mike Polark from Wolfe Research issued a price target of $200.00 for PODD on 2024-05-07 04:48:00. The adjusted price target was set to $200.00. At the time of the announcement, PODD was trading at $176.4. The overall price target consensus is at $3...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today released its 2023 Sustainability Report , which describes key accomplishments in environmental, social, and governance (E...

2024-05-06 03:26:12 ET Summary DexCom shares took a slight tumble after earnings were announced Thursday evening off of strong results. Guidance for the year was upgraded due to growing demand and FDA clearance for the Apple Watch as a primary display for blood sugars. Despite...